A multi-center, open-labelled, randomized controlled extended phase III non-inferiority clinical trial to evaluate the immunogenicity and tolerability of poliomyelitis vaccine (Vero cells), inactivated, Sabin strains administered with or without routine infant vaccines

Muhammad Atiqul Islam, Syeda Mahjabeen Zehra, Zaubina Kazi, Salman Ather, Sabeena Ahmed, Rehnuma Tabassum Timu, Aneeta Hotwani, Mohammad Sharif Hossain, Aimon Tahir, Qianqian Xin, Weixiao Han, Wasif Ali Khan, Ali Faisal Saleem

Open source

DOI: 10.1016/j.vaccine.2026.129095
Published: 2026-10
Container: Vaccine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2026.129095,
  title = {A multi-center, open-labelled, randomized controlled extended phase III non-inferiority clinical trial to evaluate the immunogenicity and tolerability of poliomyelitis vaccine (Vero cells), inactivated, Sabin strains administered with or without routine infant vaccines},
  author = {Muhammad Atiqul Islam and Syeda Mahjabeen Zehra and Zaubina Kazi and Salman Ather and Sabeena Ahmed and Rehnuma Tabassum Timu and Aneeta Hotwani and Mohammad Sharif Hossain and Aimon Tahir and Qianqian Xin and Weixiao Han and Wasif Ali Khan and Ali Faisal Saleem},
  year = {2026},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2026.129095},
  url = {https://doi.org/10.1016/j.vaccine.2026.129095}
}

RIS

TY  - JOUR
TI  - A multi-center, open-labelled, randomized controlled extended phase III non-inferiority clinical trial to evaluate the immunogenicity and tolerability of poliomyelitis vaccine (Vero cells), inactivated, Sabin strains administered with or without routine infant vaccines
AU  - Muhammad Atiqul Islam
AU  - Syeda Mahjabeen Zehra
AU  - Zaubina Kazi
AU  - Salman Ather
AU  - Sabeena Ahmed
AU  - Rehnuma Tabassum Timu
AU  - Aneeta Hotwani
AU  - Mohammad Sharif Hossain
AU  - Aimon Tahir
AU  - Qianqian Xin
AU  - Weixiao Han
AU  - Wasif Ali Khan
AU  - Ali Faisal Saleem
PY  - 2026
JO  - Vaccine
DO  - 10.1016/j.vaccine.2026.129095
UR  - https://doi.org/10.1016/j.vaccine.2026.129095
ER  -

APA

Islam, M. A., Zehra, S. M., Kazi, Z., Ather, S., Ahmed, S., Timu, R. T., Hotwani, A., Hossain, M. S., Tahir, A., Xin, Q., Han, W., Khan, W. A., & Saleem, A. F. (2026). A multi-center, open-labelled, randomized controlled extended phase III non-inferiority clinical trial to evaluate the immunogenicity and tolerability of poliomyelitis vaccine (Vero cells), inactivated, Sabin strains administered with or without routine infant vaccines. Vaccine. https://doi.org/10.1016/j.vaccine.2026.129095

Source records

crossref · retrieved 2026-09-25T21:49:06.924Z